Biotech: Pressemitteilungen - Kategorie - Seite 7

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Microbix to Amend Share Purchase Warrant Terms

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/24/17 -- Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend t ...

Ceapro Reports 2017 Second Quarter Business Update and Financial Results

EDMONTON, ALBERTA: Continued advancement for expansion into nutraceutical market Results from animal studies evaluating bioavailability of impregnated CoQ10 with beta glucan expected Q4 2017 Encouraging preliminary data ...

NetworkNewsWire Announces Publication Discussing the Companies Ready to Strike on the Canadian Legal Marijuana Industry

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 08/16/17 -- ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global (TSX VEN ...

Cosmos Holdings, Inc. Announces Second Quarter 2017 Results

CHICAGO, IL: Revenue Improved 539% and Gross Profit Improved 487% compared to the three months ended June 30, 2016 ...

VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme

CAMBRIDGE, MASSACHUSETTS: VBI-1901 is a novel immunotherapy developed using VBI's eVLP technology On track to initiate a Phase I/2a clinical study in the second half of 2017 ...

Revive Therapeutics Appoints Dr. Ram Subramanian, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/15/17 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV)(OTCQB: RVVTF), a company focused on the research, develop ...

Cleveland BioLabs Reports Second Quarter 2017 Financial Results and Development Progress

BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 08/14/17 -- (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2017.Cleveland BioLabs reported a net loss ...

Critical Outcome Technologies Completes Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies

LONDON, ONTARIO and BOSTON, MASSACHUSETTS: - COTI-2 safe and well-tolerated at doses up to 1.7 mg/kg - Company to advance into head and neck squamous cell carcinoma expansion arm ...

Microbix Reports Record Third Quarter & Nine Month Sales

TORONTO, ONTARIO: Year-Over-Year Sales Growth Exceeding 20% ...

Trillium Therapeutics Reports Second Quarter 2017 Financial and Operating Results

TORONTO, ONTARIO: Clinical responses observed in Phase 1 trial of TTI-621; Scope of trial expanded, including dose-intensification strategy; $39 million capital raise; cash and marketable securities of $72.6 million at ...

Arch Biopartners Closes Non-Brokered Private Placement Financing

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/10/17 -- Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF), announced today it has closed the non-brokered private placement the ...

Opthea to Present at the American Society of Retinal Specialists Annual Meeting and the Ophthalmology Innovation Summit

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 08/09/17 -- Opthea Limited (ASX: OPT), a developer of novel biologic therapies for the treatment of eye diseases, announced today that the Company will presen ...

Microbix Announces Expanded Customer Supply Agreement

TORONTO, ONTARIO: $25 Million of Expected Sales, With Approximately $10 Million of New Business ...

Opthea to Present at the Wedbush PacGrow Healthcare Conference

MELBOURNE, AUSTRALIA: Company Presentation Scheduled for August 15th, 2017 at 8:00AM ET ...

Theratechnologies Announces Completion of the Pre-License Inspection of the Ibalizumab Manufacturing Facility

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/02/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it has been notified by its partner, TaiMed Biologics, Inc. (TaiMed), that ...

Realm Therapeutics: Submission of Investigational New Drug Application

MALVERN, PA: MALVERN, PA -- (Marketwired) -- 08/02/17 -- Realm Therapeutics (AIM: RLM)("Realm Therapeutics", "Realm" or the "Company")Realm Therapeutics plc (AIM: RLM), a clinical st ...

Mincom Provides Update on Proposed Transaction

OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwired) -- 08/01/17 -- Mincom Capital Corporation ("Mincom" or the "Corporation") (TSX VENTURE: MOI) is pleased to provide the following update with resp ...

Bradmer Announces Second Quarter 2017 Financial Results

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/01/17 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (NEX: BMR.H) today announced its second quarter 2017 financial results. ...

Arch Biopartners Provides Update on GMP Manufacturing of AB569

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/27/17 -- Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF) today provided an update on the progress of the good manufacturing pra ...


Seite 7 von 255:  « ..  6 7 8  9  10  11  12  13  14  15  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z